Characterizing WW Domain Interactions of Tumor Suppressor WWOX Reveals Its Association with Multiprotein Networks*

  1. Rami I. Aqeilan,§§2
  1. From the Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel 91120,
  2. the §Donnelly Centre for Cellular and Biomolecular Research, Departments of Molecular Genetics and Computer Science, University of Toronto, Toronto, Ontario M5S 3E1, Canada,
  3. Al Quds-Bard Honors College, Al-Quds University, East Jerusalem, Abu Dies, Palestine,
  4. the Laboratory of Signal Transduction and Proteomic Profiling, Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822,
  5. the **Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029,
  6. the ‡‡Department of Biological Chemistry, The Alexander Silberman Institute of Life Science, Hebrew University of Jerusalem, Jerusalem 91904, Israel, and
  7. the §§Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210
  1. 2 To whom correspondence should be addressed: Lautenberg Center for Immunology and Cancer Research, Hebrew University-Hadassah Medical School, P.O. Box 12272, Ein Karem Campus, Jerusalem 91120, Israel. E-mail: ramiaq{at}mail.huji.ac.il.
  1. 1 Both authors contributed equally to this work.

Background: WWOX encodes a 46-kDa tumor suppressor.

Results: WW1 domain of WWOX mediates its protein-protein interaction with PY motifs that are involved in molecular processes, including transcription, RNA processing, and metabolism.

Conclusion: The WW1 domain of WWOX provides a versatile platform that links WWOX with individual proteins associated with physiologically important networks.

Significance: This study provides a better understanding of WWOX biology in normal and disease states.

Abstract

WW domains are small modules present in regulatory and signaling proteins that mediate specific protein-protein interactions. The WW domain-containing oxidoreductase (WWOX) encodes a 46-kDa tumor suppressor that contains two N-terminal WW domains and a central short-chain dehydrogenase/reductase domain. Based on its ligand recognition motifs, the WW domain family is classified into four groups. The largest one, to which WWOX belongs, recognizes ligands with a PPXY motif. To pursue the functional properties of the WW domains of WWOX, we employed mass spectrometry and phage display experiments to identify putative WWOX-interacting partners. Our analysis revealed that the first WW (WW1) domain of WWOX is the main functional interacting domain. Furthermore, our study uncovered well known and new PPXY-WW1-interacting partners and shed light on novel LPXY-WW1-interacting partners of WWOX. Many of these proteins are components of multiprotein complexes involved in molecular processes, including transcription, RNA processing, tight junction, and metabolism. By utilizing GST pull-down and immunoprecipitation assays, we validated that WWOX is a substrate of the E3 ubiquitin ligase ITCH, which contains two LPXY motifs. We found that ITCH mediates Lys-63-linked polyubiquitination of WWOX, leading to its nuclear localization and increased cell death. Our data suggest that the WW1 domain of WWOX provides a versatile platform that links WWOX with individual proteins associated with physiologically important networks.

Footnotes

  • * This work was supported in part by funds from Israel Science Foundation Grant 12-542 and German Israel Foundation Grant 1101-60.11/2010 (to R. I. A.); Pennsylvania Breast Cancer Coalition Grants 60707 and 920093 and the Geisinger Clinic (to M. S.); and the Lejwa Fund for Biochemistry (to D. R.).

  • Graphic This article contains supplemental Tables S1–S11.

  • Received August 2, 2013.
  • Revision received February 12, 2014.
Table of Contents

Submit your work to JBC.

You'll be in good company.